Progress by Avoidance Trumps Beijing Visit Signals Caution in USChina Ties Wix Announces 20 Workforce Reduction Amid AIDriven Restructuring Donald Trump JrBacked Enhanced Games Controversial Steroid Olympics Launches This Weekend with Broader Product Ambitions EU Dependence on China Deepens Across Solar Panels Rare Earths and Industrial Robots Sun Pharma Reports 26 Net Profit Growth in Q4 Driven by Strong Sales and Strategic Investments What Will XRP Be Worth in 10 Years A DecadeLong Perspective TRI Q1 2026 Earnings EPS Beats Estimates by 178 Stock Declines Despite Profit Surprise FRST Q1 2026 Earnings Strong EPS Surprise Driven by Core Income Strength NESR Q1 2026 Earnings EPS Beats Estimates by Nearly 20 But Stock Dips Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline UTSI Q4 2019 Earnings Significant EPS Miss Sends Stock Down FMNB Q1 2026 Earnings Strong EPS Surprise of 212 Drives Investor Attention Despite Stock Dip RAAQW Warrants Inch Up 169 as Market Eyes Key Resistance Level Avino Silver Gold Mines ASM Gains 74 Amid Silver Sector Strength Citizens Financial Group CFG Holds Steady Above 63 Amid Modest Gains NPFD Edges Higher as Investors Steady Holdings Nuveen Variable Rate Preferred Income Fund NPFD Analysis XMAX Inc XWIN Holds Steady as Consolidation Continues Near MidRange Political Transition Struggles The Churn Reflects Resistance to Andy Burnhams Rise CDZIP Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 36 Evergy Inc EVRG Holds Steady Near Support as Utility Sector Seeks Direction SOLV Q1 2026 Earnings EPS Beat by 73 Amid Operational Efficiency ODFL Q1 2026 Earnings EPS Beats Estimates Stock Rises 131 CHEF Q1 2026 Earnings Earnings Surge Past Expectations with 55 Surprise NVEC Q1 2026 Earnings EPS Comes in at 102 Shares Rise 421 Advanced Flower Capital Inc AFCG Q1 2026 Earnings EPS Surpasses Estimates with 3283 Beat TTGT Q1 2026 Earnings Significant EPS Miss as Losses Widen Stock Gains Unexpectedly PCVX Q1 2026 Earnings Wider Than Expected Loss as PreRevenue Biotech Advances Vaccine Pipeline